{"id":"naoxintong-capsule","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The capsule contains multiple herbal components that work synergistically to promote blood flow, reduce platelet aggregation, and improve microcirculation. It is believed to work through multiple pathways including anticoagulation, vasodilation, and anti-inflammatory mechanisms, though the exact molecular targets have not been fully characterized in Western pharmacological terms.","oneSentence":"Naoxintong Capsule is a traditional Chinese medicine formulation that improves blood circulation and reduces blood stasis to treat cardiovascular and cerebrovascular conditions.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:56:36.687Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Angina pectoris"},{"name":"Myocardial infarction prevention and treatment"},{"name":"Cerebral infarction and stroke prevention"}]},"trialDetails":[{"nctId":"NCT05278182","phase":"NA","title":"A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2022-12","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":80},{"nctId":"NCT02334969","phase":"PHASE4","title":"Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM","status":"COMPLETED","sponsor":"Xiaofei Yu","startDate":"2016-04","conditions":"Ischemic Stroke","enrollment":2200},{"nctId":"NCT01762163","phase":"PHASE4","title":"Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke","status":"COMPLETED","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2013-10","conditions":"Ischemic Stroke","enrollment":622}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HEPATIC FUNCTION ABNORMAL"}],"_approvalHistory":[],"publicationCount":74,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Chinese Herbal Compound","NXT group"],"phase":"marketed","status":"active","brandName":"Naoxintong Capsule","genericName":"Naoxintong Capsule","companyName":"Chinese Academy of Medical Sciences, Fuwai Hospital","companyId":"chinese-academy-of-medical-sciences-fuwai-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Naoxintong Capsule is a traditional Chinese medicine formulation that improves blood circulation and reduces blood stasis to treat cardiovascular and cerebrovascular conditions. Used for Angina pectoris, Myocardial infarction prevention and treatment, Ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}